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clinical case report
Six new cases confirm the clinical 
molecular profile of complete 
combined 17α-hydroxylase/ 
17,20-lyase deficiency in Brazil
Seis novos casos confirmam o perfil clínico molecular de deficiência 
combinada de 17 alfa-hidroxilase/17,20-liase no Brasil
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da Rocha Grassiotto3, Cristina Laguna Benetti Pinto3, Antonia Paula 
Marques-de-Faria4, Andréa Trevas Maciel-Guerra4, Gil Guerra-Júnior5
SUMMARY
In 2004, Costa-Santos and cols. reported 24 patients from 19 Brazilian families with 
17α-hydroxylase deficiency and showed that p.W406R and p.R362C corresponded to 50% and 
32% of CYP17A1 mutant alleles, respectively. The present report describes clinical and mole-
cular data of six patients from three inbred Brazilian families with 17α-hydroxlyse deficiency. 
All patients had hypogonadism, amenorrhea and hypertension at diagnosis. Two sisters were 
found to be 46,XY with both gonads palpable in the inguinal region. All patients presented 
hypergonadotrophic hypogonadism, with high levels of ACTH (> 104 ng/mL), suppressed plas-
matic renin activity, low levels of potassium (< 2.8 mEq/L) and elevated progesterone levels 
(> 4.4 ng/mL). Three of them, including two sisters, were homozygous for p.W406R mutation 
and the other three (two sisters and one cousin) were homozygous for p.R362C. The finding of 
p.W406R and p.R362C in the CYP17A1 gene here reported in additional families, confirms them 
as the most frequent mutations causing complete combined 17α-hydroxylase/17,20-lyase defi-
ciency in Brazilian patients. Arq Bras Endocrinol Metab. 2010;54(8):711-6
SUMÁRIO
Em 2004, segundo Costa-Santos e cols., p.W406R e p.R362C correspondiam a 50% e 32% dos ale-
los mutantes do gene CYP17A1, respectivamente, em 24 pacientes de 19 famílias brasileiras com 
deficiência da 17α-hidroxilase. Apresentamos os dados clínicos e moleculares de seis pacientes 
de três famílias consanguíneas brasileiras com deficiência da 17α-hidroxilase. Todas as pacientes 
apresentavam hipogonadismo, amenorreia e hipertensão ao diagnóstico. Duas irmãs tinham 
cariótipo 46,XY, ambas com gônadas palpáveis na região inguinal. Todas tinham hipogonadismo 
hipergonadotrófico, com nível aumentado de ACTH (> 104 ng/mL), atividade de renina plasmáti-
ca suprimida, baixos níveis de potássio (< 2,8 mEq/L) e progesterona aumentada (> 4,4 ng/mL). 
Três delas, incluindo duas irmãs, apresentaram homozigose para a mutação p.W406R e as outras 
três (duas irmãs e uma prima) foram homozigotas para a mutação p.R362C. A recorrência das 
mutações p.W406R e p.R362C no gene CYP17A1 aqui relatada em famílias adicionais confirma 
que essas são as mais frequentes causadoras do fenótipo completo da deficiência combinada de 
17α-hidroxilase/17,20-liase em pacientes brasileiros. Arq Bras Endocrinol Metab. 2010;54(8):711-6
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INTRODUCTION
The microsomal cytochrome P450c17 is a single en-zyme with two catalytic functions, 17α-hydroxylase 
and 17,20-lyase, which plays a crucial role in the biosyn-
thesis of cortisol and sex steroids. Deficiency of P450c17 
(17OHD) in both the adrenal cortex and gonads results 
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Complete 17-hydroxylase/17,20-lyase deficiency
in impaired production of cortisol and sex hormones, 
leading to hypersecretion of ACTH and overproduc-
tion of mineralocorticoids (1,2). 
P450c17 is encoded by the CYP17A1 gene (OMIM 
609300), which is located at 10q24.3 and contains 
eight exons (3-5). 17OHD is a rare form of congenital 
adrenal hyperplasia (CAH) with an estimated incidence 
of about 1:50,000 newborns (1), which represent 1% of 
all cases of CAH. Most reports describe isolated cases 
in consanguineous families (2), and approximately 50 
different mutations in CYP17A1 have been described, 
although some are more common and reoccur in cer-
tain ethnic groups. Most mutations have been seen to 
cause combined 17α-hydroxylase/17,20-lyase enzyme 
deficiency (1,2,6-17).
Typical features of complete 17OHD include hy-
pertension, hypokalemia, and sexual infantilism in 
genotypic-phenotypic females, and as incomplete male 
sex differentiation with ambiguous or female genita-
lia, and also sexual infantilism in 46,XY subjects (1,2). 
Nevertheless, there is considerable variation in clinical 
and biochemical features of 17OHD (18), including 
the variant of isolated 17,20-lyase deficiency (19). The 
severity of the clinical disease tends to be milder with 
mutations that retain partial catalytic activity in assays 
using heterologous expression systems (1), but the age 
of hypertension onset, the degree of hypokalemia, and 
the aldosterone production rate appear to vary, even 
among patients with mutations that completely inacti-
vate the enzyme (2).
In 2004, Costa-Santos and cols. (9) published clini-
cal and molecular data of 24 patients with 17OHD 
from 19 kindreds from the Brazilian Congenital Adre-
nal Hyperplasia Multicenter Study Group and showed 
seven novel CYP17 mutations. Two of them, p.W406R 
and p.R362C accounted for 50% and 32% of the mu-
tant alleles (9).
We describe here clinical and molecular data of six 
additional Brazilian patients with 17OHD from three 
different kindreds.
CASE REPORTS
Clinical data and blood specimens of the patients and 
relatives were collected with approval by the appropri-
ate institutional review board and a signed informed 
consent was obtained.
Tables 1 and 2 show clinical, biochemical and hor-
monal data from the six patients with 17OHD.
Patient 1 presented at age 15 because of absence of 
pubertal development signs (failure of breast develop-
ment, absence of pubic hair and menarche). She had 
systolic hypertension (170/110 mmHg) since she was 
14 years old. Her parents were second cousins. She 
had had four older sisters of unknown genetic sex who 
died at the ages of 5, 7, 9 and 13. The oldest sister, 
who died in her sleep, was also prepubertal and had 
hypertension. 
Patients 2.1 and 2.2 are siblings born to consan-
guineous parents (first cousins). They were raised as 
girls and were examined at 17 and 18 years of age, 
respectively, because of lack of pubertal development 
(failure of breast development, absence of pubic hair 
and menarche). Both had hypertension since they were 
12 years old (170/110 mmHg and 180/120 mmHg, 
respectively). Patient 2.2 had a stroke with permanent 
partial right facial paralysis by the time of hypertension 
diagnosis. They presented prepubertal female external 
genitalia with bilateral inguinal gonads but no uterus at 
ultrasound. Their karyotypes were both 46,XY. 
Table 1. Clinical and biochemical features of 17OHD patients
Case Age at diagnosis (yr) Karyotype
External 
genitalia Sex of rearing BP (mmHg)
Na
(mEq/L)
K
(mEq/L)
1 15 46,XX F F 170/110 142 2.5
2.1 17 46,XY F F 170/110 141 2.6
2.2 18 46,XY F F 180/120 150 2.6
3.1 19 46,XX F F 180/110 149 2.7
3.2 18 46,XX F F 160/100 144 2.7
3.3 14 46,XX F F 160/100 142 2.8
Normal values 136 – 146 3.5 – 5.5
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Complete 17-hydroxylase/17,20-lyase deficiency
Table 2. Plasma basal hormonal values in 17OHD patients
1 2.1 2.2 3.1 3.2 3.3 Normal values (adult female)
LH (IU/L) 31.2 26.1 67.3 30.5 28.9 25.2 1.9 – 12.5
FSH (IU/L) 50.0 52.5 81.7 80.6 75.7 88.2 1.5 – 8.0
ACTH (pg/mLl) 185 102 274 309 256 104 < 46
Cortisol (μg/dL) 2.4 2.2 2.6 2.8 2.6 2.6 5.0 – 25.0
PRA (ng/ml/h) 0.3 05 0.3 0.3 0.4 0.3 0.1 – 2.3 
Progesterone (ng/mL) 4.4 5.0 4.9 4.6 6.6 8.4 0.1 – 1.4 
17-OHprogesterone (ng/mL) 0.3 0.5 0.2 0.6 0.3 0.2 0.2 – 1.5 
DHEA (ng/mL) 0.5 0.8 0.6 1.1 0.9 0.8 3.0 – 6.1
DHEA-S (μg/dl) 50 44 62 55 60 40 80 – 560 
Androstenedione (ng/mL) 0.2 0.3 0.2 0.2 0.3 0.2 0.7 – 3.6
Testosterone (ng/dL) 0.06 0.06 0.08 0.06 0.06 0.08 0.06 – 0.85 
 
3.2 3.33.1
Patients 3.1 and 3.2 are siblings born to consan-
guineous parents (first cousins) (Figure 1). They pre-
sented at the age of 18 and 19 because of absence of 
pubertal development signs (failure of breast develop-
ment, absence of pubic hair and menarche) and hyper-
tension (180/110 mmHg and 160/100 mmHg, re-
spectively). They were prepubertal with female external 
genitalia. Their karyotypes were both 46,XX. 
Patient 3.3 is a cousin of 3.1 and 3.2 and was also 
born to consanguineous parents (first cousins) (Figure 1). 
She was evaluated at the age of 14 because of delayed 
puberty (failure of breast development, absence of 
pubic hair and menarche). Hypertension was noticed 
during clinical evaluation (160/100 mmHg). Physical 
examination revealed absence of breast development, 
pubic and axillary hair with normal infantile female ex-
ternal genitalia. Her karyotype was 46,XX. 
Figure 1. Pedigree of family 3.
Genomic DNA samples were obtained from pe-
ripheral blood by Proteinase K digestion and phenol/
chloroform extraction following standard techniques. 
Primers for PCR amplifying the eight exons including 
exon-intron junctions of CYP17A1 gene were designed 
using GeneRunner v3.0 free software. The amplified 
fragments were purified with Wizard SV Gel and PCR 
Clean-up System (Promega, Madison, WI, USA) and 
both sense and antisense DNA strands were directly se-
quenced with Big Dye Terminator Cycle Sequencing 
Kit V3.1 Ready Reaction (ABI PRISM/PE Biosystems, 
Foster City, CA, USA). Sequencing reactions were elec-
trophoresed in a ABI PRISM 3700 Automated DNA 
Sequencer capillary system according to the manufac-
turer’s recommendations (ABI PRISM/PE Biosys-
tems, Foster City, CA, USA). Sequences obtained were 
compared to the normal CYP17A1 genomic sequence 
(ENSG00000148795).
Patients 1, 2.1 and 2.2 showed the nucleotide 
change c.1388T>C in exon 7. The three patients were 
homozygous for the mutation that causes amino acid 
substitution p.W406R (Figure 2A). The CYP17A1 se-
quence analysis of patients 3.1, 3.2 and 3.3 revealed a 
c.1256C>T homozygous transition in codon 362 lo-
cated in exon 6. This nucleotide substitution leads to 
the p.R362C missense mutation (Figure 2B). Patients 
homozygous for p.R362C mutations were also ho-
mozygous for the less frequent allele of the following 
polymorphisms: rs743572 (5’UTR), rs6162 (exon 1), 
rs6163 (exon 1), rs743575 (intron 2), rs3740397 (in-
tron 5), rs4919686 (intron 6), rs10883783 (intron 7) 
and a novel IVS-130del35bp. The deletion of 35 bp in 
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Figure 2. Eletropherograms showing parts of the CYP17A1 gene sequences. A) Exon 7; the arrow denotes the c.1388T>C change causing the p.W406R 
mutation found in patients 1, 2.1 and 2.2. B) Exon 6; the arrow denotes the c.1256C>T change causing the p.R362C mutation found in patients 3.1, 3.2 and 
3.3. N = normal sequence; M = mutant sequence.
A
B
intron 7 must be a frequent polymorphism in Brazilian 
population since it was found in 15.6% control alleles. 
Unfortunately, DNA samples of their parents were not 
available for analysis to confirm the segregation of mu-
tations. However, patients have been considered ho-
mozygous for either p.W406R or p.R362C mutations 
without investigating microsatellites heterozygosis due 
to close consanguinity between parents and also due to 
the fact that CYP17A1 gene deletions have never been 
reported.
DISCUSSION
The possibility of studying the CYP17A1 gene of sever-
al patients affected by the rare 17α-hydroxylase/17,20-
lyase deficiency is an effective tool to clarify the molecu-
lar mechanisms and genetic characteristics of the disease 
and also to gather more information about the struc-
ture-function relationship of this protein. P450c17 can 
be considered the qualitative regulator of steroidogen-
esis by determining which kind of steroids will be pro-
duced: mineralocorticoids in which P450c17 is absent, 
glucocorticoids when 17α-hydroxylation is active, and 
sex hormones when 17,20-cleavage takes place. There-
fore, the knowledge concerning P450c17 will always 
be of great impact for understanding hypertension, ad-
renarche, puberty, and hyperandrogenism, with obvi-
ous implications in fertility.
Homozygous carriers of either p.W406R or 
p.R362C mutations have been described as presenting 
hypertension, hypokalemia, and sexual infantilism (9); 
a typical phenotype observed in complete combined 
17α-hydroxylase/17,20-lyase deficiency (19). The six 
patients reported here, who were all born to consan-
guineous parents, also presented a complete combined 
17α-hydroxylase/17,20-lyase deficiency phenotype, 
with moderate to severe hypertension, hypokalemia (< 
2.8 mEq/L), elevated ACTH (> 104 ng/mL) and pro-
gesterone (> 4.4 ng/mL) with low levels of cortisol and 
17OH-progesterone, and sexual infantilism (in both 
Complete 17-hydroxylase/17,20-lyase deficiency
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46,XX and 46,XY subjects) with low levels of DHEA, 
DHEA-S, androstenedione and testosterone and high 
levels of LH and FSH. As showed by Martin and cols. 
(8), our data confirmed the importance of evaluating 
LH, FSH, ACTH, progesterone, and potassium and/or 
plasmatic renin activity to diagnose complete combined 
17α-hydroxylase/17,20-lyase deficiency. A good geno-
type-phenotype correlation is therefore observed since 
p.W406R and p.R362C mutations showed no residual 
enzymatic activity in expression studies using COS-7 or 
HEK-293 cells and in yeast, indicating that the result-
ing phenotype for both mutations is the complete com-
bined 17α-hydroxylase/17,20-lyase deficiency (9). 
According to Costa-Santos and cols. (9), p.W406R 
and p.R306C account, respectively, for 50% and 32% 
of CYP17A1 mutant alleles among Brazilian patients. 
The majority of affected individuals carrying p.W406R 
or p.R362C mutations are of Spanish or Portuguese 
descent, respectively (9). In contrast, no other muta-
tion among almost 50 in the CYP17 gene is related to 
patients of Spanish or Portuguese origin (1,2,6,7,10-
12,14-17). Brazilians form one of the most heteroge-
neous populations in the world, as the result of more 
than five centuries of miscegenation from the four con-
tinents: America, Europe, Africa, and Asia. When the 
Portuguese arrived in Brazil in the year 1500, around 
2.5 million South American Indians already lived in the 
country. The initial colonization involved almost exclu-
sively Portuguese men, therefore, the first miscegena-
tion occurred between European men, mainly Portu-
guese, and native Indian women. Between the years of 
1500 and 1800 around half a million Portuguese men 
arrived in Brazil. Since the middle of the century to 
1855, around four million African slaves came to Bra-
zil. In 1808, Portuguese royalty moved from Portugal 
to Brazil and opened the ports to all nations. Between 
1820 and 1975, around six million immigrants offi-
cially arrived in Brazil; 70% Portuguese and Italians, in 
equal numbers, followed by the Spanish, Germans, Syr-
ians, Lebanese and Japanese (20). So, it is very difficult 
to define the correct ancestry of Brazilian patients, but 
the families included in the present study reported to 
have Spanish (patients 1, 2.1 and 2.2, all from Lagoa 
Santa – State of Minas Gerais – Brazil) and Portuguese 
(patients 3.1, 3.2 and 3.3, all from Jeremoabo – State 
of Bahia – Brazil) origins, confirming the data of Costa-
Santos and cols. (9). The homozygosity for the less fre-
quent allele in several polymorphisms found in patients 
3.1, 3.2 and 3.3 might also indicate that this mutant 
allele corresponds to a rare CYP17A1 haplotype intro-
duced in Brazil by Europeans.
In conclusion, we confirm p.W406R and 
p.R362C mutations as causes of complete combined 
17α-hydroxylase/17,20-lyase deficiency; a high gen-
otype-phenotype correlation is observed for mutation 
carriers; and also they are the most frequent mutations 
in Brazilian patients, specially those with Spanish or 
Portuguese ancestry. 
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